학술논문

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Document Type
Article
Source
In: Journal of Experimental and Clinical Cancer Research. (Journal of Experimental and Clinical Cancer Research, December 2022, 41(1))
Subject
Language
English
ISSN
17569966